Monday, February 28, 2022

Health Matters for Women - February 2022

 

 

February 2022 

 

 

New from CDC

 

Lower Your Risk for the Number 1 Killer of Women

February is Heart Health Month! Learn about heart disease and women and what you can do to keep a healthy heart.

 

Assisted Reproductive Technology (ART) Surveillance-United States, 2018

Long-term follow-up of ART infants through integration of existing maternal and infant health surveillance systems and registries with data available from NASS might be useful for monitoring adverse outcomes on a population basis.

 

HPV Prevalence Among Young Adult Women Living With and Without HIV in Botswana for Future HPV Vaccine Impact Monitoring

This study supports need for the national HPV vaccination program in Botswana and provides important baseline data for future evaluation of impact of the program.

 

Measles Susceptibility in Maternal-infant Dyads - Bamako, Mali

Authors investigated the relationship between maternal age and measles susceptibility in mother-infant pairs in Mali through six months of infancy.

 

Sexual Violence Prevalence and Related Pregnancy Among Girls and Young Women: A Multicountry Analysis

This study aims to quantify the prevalence of forced sex, pressured sex, and related pregnancy among adolescent girls and young women in five low- and middle-income countries.

 

Cervical Precancers and Cancers Attributed to HPV Types by Race and Ethnicity: Implications for Vaccination, Screening, and Management

Authors examined racial and ethnic variations in attribution of cervical precancer and cancer to HPV types may result in different HPV vaccine protection, screening test coverage, and clinical management.

 

HIV Care Outcomes Among Transgender Persons with HIV infection in the United States, 2006-2021

HIV prevalence is an estimated 14% among transgender women and 3% among transgender men. HIV care is vital for viral suppression but is hindered by transphobia and HIV stigma. Authors assessed HIV care outcomes among transgender persons with HIV in the United States.

 

Diverging Trends in US Male-Female Condom Use by STI Risk Factors: A Nationally Representative Study

Condom use behaviors are proximal to recent STI increases in the USA, yet it remains unclear whether the use of condoms has changed over time among unmarried, non-cohabiting young men who have sex with women and how this variability is influenced by STI risk factors.

 

Are Experiences of Racial Discrimination Associated with Postpartum Depressive Symptoms? A Multistate Analysis of Pregnancy Risk Assessment Monitoring System Data

Authors examined whether interpersonal racial discrimination is associated with higher odds of postpartum depressive symptoms among women of color and how it may vary by race/ethnicity and maternal educational attainment.

 

Cervical Cancer Screening and Treatment, HIV infection, and Age: Program Implementation in Seven Regions of Namibia

The aim of this study was to assess differences in cervical cancer screening and treatment outcomes by HIV status in a routine programmatic setting with a high generalized HIV prevalence. 

 

Disparities in Breast-Conserving Therapy for Non-Hispanic American Indian/Alaska Native Women Compared with Non-Hispanic White Women

The purpose of this study is to determine whether there are disparities in breast cancer surgery and radiation therapy between non-Hispanic AI/AN women and non-Hispanic White women.

 

A Field Placement Approach to Enhance State and Local Capacity for Opioid-Related Issues Affecting Pregnant and Postpartum People and Infants Prenatally Exposed to Opioids and Other Substances

This report describes the implementation of a temporary field placement approach and suggests that this approach could be replicated to enhance state and local capacity to respond to the opioid crisis or other high-consequence events.

 

Characteristics and Outcomes of Hospitalized Pregnant Women With Influenza, 2010 to 2019 : A Repeated Cross-Sectional Study

Pregnant women may be at increased risk for severe influenza-associated outcome. This report describes characteristics and outcomes of hospitalized pregnant women with influenza.

 

Variation in Patterns of Racial and Ethnic Disparities in Primary and Secondary Syphilis Diagnosis Rates Among Heterosexually Active Women by Region and Age Group in the United States

Authors assessed whether racial and ethnic disparities in primary and secondary syphilis among heterosexually active women differ by region and age group.

 

 

COVID-19 Impact on Women

 

Effectiveness of Maternal Vaccination with mRNA COVID-19 Vaccine During Pregnancy Against COVID-19 Associated Hospitalization in Infants Aged <6 Months---17 states, July 2021-January 2022.

Completion of a 2-dose mRNA COVID-19 vaccination series during pregnancy might help prevent COVID-19 hospitalization among infants aged<6 months.

 

Colombia Increases Surveillance to Protect Pregnant Women Against COVID-19

Throughout the COVID-19 pandemic, Colombia, like many other countries, has been challenged to rapidly identify and protect the most vulnerable groups from COVID-19.

 

Pediatric Department Visits Associated with Mental Health Conditions Before and During the COVID-19 Pandemic-United States. January 2019-January 2022.

Early identification and expanded evidence-based prevention and intervention strategies are critical critical to improving pediatric mental health, especially among adolescent females, who might have increased need.

 

COVID-19 Vaccination Coverage and Vaccine Confidence by Sexual Orientation and Gender Identity — United States, August 29–October 30, 2021

Lesbian, gay, bisexual, and transgender (LGBT) persons are at increased risk for severe COVID-19 illness because of a higher prevalence of comorbidities. To prevent serious illness and death, all persons in the United States, including those in the LGBT community, should stay up to date with recommended COVID-19 vaccinations.

 

Sensitivity of Pregnancy Field on the COVID-19 Case Report Form Among Pregnancies Completed Through December 31, 2020: Illinois and Tennessee

The considerable volume of infections from SARS-CoV-2, the virus that causes COVID-19, has made it challenging for health departments to collect complete data for national disease reporting. Authors sought to examine sensitivity of the COVID-19 case report form (CRF) pregnancy field by comparing CRF data to the gold standard of CRF data linked to birth and fetal death certificates.

 

Snapshots

 

National, State, Territorial and Local 

Why Pregnant People Were Left Behind While Vaccines Moved at ‘Warp Speed’ to Help the Masses - Kaiser Family Foundation 

Medicaid Coverage for Women - Kaiser Family Foundation

Family Planning and Contraceptive Provision Among Females Enrolled in Medicaid - Kaiser Family Foundation

Congenital Cytomegalovirus Approved for Addition to Newborn Screening Panel - MN

DHS to Request 30-day Extension of Medicaid Coverage for Women After Pregnancy - WI

Journal of Women's Health

Research on Women's Health: Ready for the Future

A Field Placement Approach to Enhance State and Local Capacity for Opioid-Related Issues Affecting Pregnant and Postpartum People and Infants Prenatally Exposed to Opioids and Other Substances

 

 

 

Health Observances, March 2022

National Endometriosis Awareness Month

Colorectal Cancer Awareness Month

3/10 National Women and Girls HIV/AIDS Awareness Day

 

If you're having trouble reading this message, click here

This service is provided by the CDC/ATSDR Office of Women's Health. Email comments or suggestions to owh@cdc.gov.

For more information about women’s health, visit www.cdc.gov/women.

Disclaimer:
Links to non-Federal organizations are provided solely as a service to our users. These links do not constitute an endorsement of these organizations or their programs by CDC/ATSDR or the Federal Government, and none should be inferred. The CDC/ATSDR is not responsible for the content of the individual organization Web pages found at these links.

CDC Facebook

CDC Twitter

CDC Streaming Health

CDC Instagram

 

Centers for Disease Control and Prevention

1600 Clifton Rd   Atlanta, GA 30329   1-800-CDC-INFO (800-232-4636)   TTY: 888-232-6348


No comments:

Post a Comment